Testicular Tissue Producing Insulin: A Cure?

Studies show that men who have type 1 diabetes might be able to grow their own insulin-producing cells from their testicular tissue.

Testicular Tissue Producing Insulin - A CureTesticular Tissue Producing Insulin – A Cure: Studies show that men who have type 1 diabetes might be able to grow their own insulin-producing cells from their testicular tissue. This new discovery comes from researchers at the Georgetown University Medical Center.

There are more than 23 million people in the United States alone, who have been diagnosed with diabetes. That 23 million includes women, men, and children. On a yearly basis, another million will be diagnosed with diabetes as well. It is growing epidemic and many people who do not have a family history of diabetes are being diagnosed with it as well. Both laboratory and animal studies are held every day in hopes of finding a new cure for diabetes and sometimes there are great advances.

The newest advance comes from the researchers at the Georgetown University Medical Center where researchers have proven through studies that human spermatogonial stem cells also known as SSC’s, which are extracted from testicular tissue, can alter into insulin-producing beta islet cells, which are normally found in the pancreas. The researchers, who discovered this, say that this study has been accomplished without the use of extra genes, which are used by most labs today to turn adult stem cells into a tissue of choice.

Through years of study, there have been some great discoveries made in the world of health science and diabetes. Even mice have been cured of their diabetes through the use of induced pluripotent stem cells also known as IPS cells, but some of these studies have also had their drawbacks as well. Through certain studies, islet cells have been transplanted from deceased donors, but soon rejections and a lack of deceased donation became an issue, leading to an unsuccessful study. Adult stem cells have also been re-programmed with other genes so that they behave just like embryonic stem cells, however this study led to transfected tissue, teratomas and tumors.

Researchers quickly turned to SSC’s rather than ISP’s for their research. SSC’s already have the source that is needed in stem cells; therefore they need no further coaxing that could lead to future health issues. Dr. Ian Gallicano, an associate professor in the Department of Cell Biology and Director of the Transgenic Core Facility at Georgetown University stated in a meeting, “We found that once you take these cells out of the testes niche, they get confused, and will form all three germ layers within several weeks. These are true, pluripotent stem cells.”

This is how it works:

One gram of tissue is extracted from the human testicle, from this one million stem cells were produced, which showed many biological indicators that illustrated normal beta islet cells. These cells were transplanted back into the immune deficient diabetic mice. A week later, there was a decrease in glucose levels.

The results lasted only a week, but through extensive studies, researchers believe that they are on the right track to producing a cure for type 1 diabetes.

The lead investigator, Gallicano also stated in his meeting, “No stem cells, adult or embryonic, have been induced to secrete enough insulin yet to cure diabetes in humans, but we know SSCs have the potential to do what we want them to do, and we know how to improve their yield.”

Depression And Diabetes: Symptoms

Depression And Diabetes - SymptomsDepression And Diabetes – Symptoms: The connection between diabetes and depression hands out scary statistics, especially for women. The statistics do not show that every person who obtains diabetes in their lifetime develops depression as well, but it is a huge possibility. Studies have proven that women who have diabetes are 29 percent more likely to develop depression than women who do not have diabetes and for those patients who use insulin to control diabetes are 53 percent more likely to develop depression.

What causes depression in diabetes to occur? Many believe the cause of depression is due to lack of diabetic management while others believe that daily stress of managing diabetes can lead to depression.

Lack of Diabetic Management– A person with diabetes has a lot of things to do during the day to take care of themselves so that diabetes does not control their life. If diabetes is not managed properly than diabetic symptoms can mask themselves as depression symptoms, making you feel very sad and unlike yourself.

Daily Stress of Diabetes Management– People who have diabetes realizes the daily stress as they are the ones who have to draw blood several times during the day and take their blood sugar. This can interfere with daily life, especially when trying to enjoy events with friends and family members. If a person has to stop the whole event just to take their blood sugar, they began to feel almost like a burden. It can cause a certain amount of stress, which in turn can cause depression.

The most important thing to do when you believe depression or diabetes can be a health issue in your life is to talk to your doctor. However, you should know both symptoms so that you can tell your doctor exactly what you  have been feeling.

Depression Symptoms

  • Sadness that lasts past two weeks and does not get better
  • Irregular feelings of guilt or hopelessness
  • Thoughts or attempts of suicide, a want to end your life
  • Muscle pains on a daily basis
  • Overeating or Under-eating

Diabetes Symptoms

  • Numbness or tingling in your legs, arms, toes or fingers
  • Pain in your hands or feet
  • Seeing black spots
  • A dizzy feeling, that makes you feel uncomfortable
  • Increased thirst

Diabetes can be hard to manage, but even harder when depression enters the picture. If you have diabetes and find yourself feeling a bit sad, talk with your doctor. They may be able to prescribe an anti-depressant that will help you feel better. When you have diabetes the best thing you can do to help stay away from depression is to manage your diabetes very well. Take your insulin, take your daily blood sugar tests, eat healthy, get in a bit of exercise and remember to talk to your doctor about any changes you are feeling.

Blood Testing Strip Recall – Abbott Diabetes

Blood Testing Strip Recall - Abbott DiabetesBlood Testing Strip Recall – Abbott Diabetes: For questions, please contact Abbott Diabetes Care at the following:

English: 800-448-5234
Español: 800-709-7010

Update: Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico

* No other Abbott Diabetes Care products are affected
* More information is available at: www.precisionoptiuminfo.com

ALAMEDA, Calif. Dec. 23, 2010 — Abbott Diabetes Care today announced that it has initiated a recall of 359 lots (approximately 359 million strips) of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico.

The test strips are used with Abbott’s Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium and OptiumEZ blood glucose monitoring systems. ReliOn Ultima test strips are used with the ReliOn Ultima blood glucose monitoring system. The blood glucose monitors are not being recalled and customers can continue to use the blood glucose monitors.

The affected test strips may give falsely low blood glucose results, which can lead users to try to raise their blood glucose when it is unnecessary and to fail to treat elevated blood glucose due to a falsely low reading. The problem appears to be related to longer than expected blood fill times. This may be dependent on the age of the strips and if the strips have been stored in (or exposed to) higher temperatures (above 72°F and not to exceed 86°F) for an extended period of time.

Customers who have test strips from these affected lots should discontinue use of the product. Abbott Diabetes Care will replace affected test strips at no charge. Abbott Diabetes Care initiated this recall following a routine internal quality review that indicated certain lots of Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ and ReliOn Ultima blood glucose test strips may experience longer than normal blood fill times which may cause falsely low blood glucose readings.

Customers are advised to contact their health care provider to determine testing options if they do not have any unaffected test strips to use.

However, if consumers must use affected test strips while in the process of obtaining new strips, they should:

1. Check the amount of time it takes for their blood glucose meter to start the “countdown” after they first apply blood to the test strip. They should start timing immediately after blood first makes contact with the test strip. If the meter takes longer than five seconds to start the countdown, that test strip is affected and the result should not be used. Users should check the time for each test strip they use because all of the strips in a package may not be affected to the same degree. If any reading appears lower than they would expect or does not seem to correlate with the way they are feeling, the user should contact their health care provider immediately.
2. If they do not immediately have access to unaffected strips and are unable to test their blood sugar, users need to be aware of symptoms of high blood sugar (hyperglycemia) and low blood sugar (hypoglycemia).
* Symptoms of high blood sugar include excessive thirst, excessive urination, blurred vision, weakness, nausea, vomiting, and abdominal pain. If a user is experiencing any of these symptoms or is not feeling well, they should contact their health care professional immediately.
* Symptoms of low blood sugar may include trembling, excessive sweating, weakness, hunger, confusion, and headache. Some individuals may have no symptoms at all before they develop unconsciousness or seizures. It is important to treat low blood sugars promptly to avoid loss of consciousness or a seizure. If a user is unable to obtain unaffected strips, they should contact their health care provider for advice on how to treat these symptoms before they occur.

The recommendation is that hospitals and user facilities stop using the recalled test strips and follow the steps below:

1. Use test strips from unaffected lots.
2. If the health care facility does not have any test strips from unaffected lots but has an alternative point-of-care blood glucose testing system, begin using the alternative system until new, unaffected test strips can be obtained.
3. If the health care facility does not have any test strips from unaffected lots or immediate access to an alternative point-of-care blood glucose testing system, health care providers should take the following steps:
* Verify any critical glucose test results (e.g., test results that may be used to adjust insulin therapy in vulnerable patient populations) generated on the Precision Xceed Pro Blood Glucose Monitoring System using a central laboratory blood glucose method. Clinical judgment should be applied when deciding whether to act on results prior to verification.
* Verify any Precision Xceed Pro Blood Glucose Monitoring System results that do not match a patient’s symptoms, or seem unexpected for the patient’s clinical status, using a central laboratory blood glucose method.
* Monitor the amount of time it takes for the Precision Xceed Pro Blood Glucose Meter to start the “countdown” after blood is first applied to the test strip. If the amount of time exceeds five (5) seconds, discard that test strip immediately because the blood glucose result may be erroneously low. In addition, if this occurs:

o Note the specific lot number of that test strip;
o Notify Abbott Diabetes Care to report the observed problem with that lot by calling 1-877-529-7185;
o Make sure to check fill time on each individual strip during use and do not assume if one strip in a package/lot appears to be unaffected, that all strips in that package/lot are unaffected.

Customers can check if they have test strips from the affected lots by visiting www.precisionoptiuminfo.com and looking up their product lot number.

Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ and ReliOn Ultima customers can also get information by calling Abbott Diabetes Care customer service at 1-800-448-5234 (English) and 1-800-709-7010 (Español).

The website and customer service phone numbers listed above will also provide customers with information about returning affected test strips.

Unaffected Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ and ReliOn Ultima Blood Glucose Test Strip lots may be used by customers to test their blood glucose as directed by their health care providers.

Abbott Diabetes Care has reported this situation to the U.S. Food and Drug Administration and is working to make the necessary corrective actions to prevent this situation from recurring.

Can Cell Switching Help Diabetes?

Can Cell Switching Help DiabetesCan Cell Switching Help Diabetes: Diabetes is a very tough health issue that millions of people around the world deal with every single day. Those who have diabetes know how disconcerting it is to have to stop mid-day and do a blood test. Diabetes takes a lot out of a person and when it is not treated; there are so many wrong things that can happen in the future from toe amputations to blindness.

Look for the signs when it comes to diabetes because diabetes is a disease that can sneak up on us all. Here are some strong symptoms to look for:

  • Numbness or tingling in your legs, arms, toes or fingers
  • Pain in your hands or feet
  • Seeing black spots
  • A dizzy feeling, that makes you feel uncomfortable
  • Increased thirst

Based off records from the American Diabetes Association, “23.6 million children and adults in the United States, or 7.8% of the population have diabetes. An estimated 17.9 million have been diagnosed with diabetes and more than 5.7 million people do not even realize that they have diabetes.

It is important no matter what promises or theories come into view that you make sure you continue to manage your diabetes. It is great that there are always medical advancements happening but there is no time frame to any of the new theories in medical advancements.

Due the ever-changing results in medical advancements and research there is always something changing that helps give hope to those suffering from different illnesses. Now, scientists are reporting about early success in altering one kind of particular cell into another, which many help patients heal in the future.

For example, if a person were to have a heart attack that damages the muscle tissue around the heart than some day in the future, doctors might be able to take other cells and make them become muscle tissue to help the heart pump.

This is all futuristic and nothing is promised but theory is more than just an idea. Many people believe that this is the very first step in stem-cell biology. It is pretty much fast-forwarding cell growth, which originally happens with injury healing.

Stem cell research is helping in so many areas and so many illnesses are finding new cures that one day, even cancer might have a cure.

Switching cells looks very prominent for the future and may give so many people much needed relief from everyday stress and wear/tear on their bodies due to diabetes and other illnesses.

Cells That Reduce Autoimmune Attacks

Cells That Reduce Autoimmune AttacksCells That Reduce Autoimmune Attacks: Diabetes is a growing epidemic. In fact, more than 24 million Americans have diabetes and a little more than 57 million individuals are pre-diabetic, which means they are right on the border of becoming a full blown diabetic. Diabetes affects so many people’s lives that it has become the number seven killer in the United States. Annually, more children develop diabetes through hereditary genes and an obesity rate that just keeps skyrocketing. Elderly patients seem to have diabetes worse than anyone else and many end up losing their life to the disease of diabetes.

Each year comes a new generation of diabetics who are hopeful that one day, advancements in medical research will find a cure. With that being said scientists might have accomplished just that.

Through recent investigative medical studies, issued by researchers at the Dana Falber Cancer Institute and Harvard Medical School Department of Pathology, a new advancement has appeared that just might help break the ever-growing cycle of autoimmune attacks that occur within the body destining individuals with life-long illnesses such as lupus, cancer and even type 1 diabetes. A connection has been made between the function of cells and the reduction of autoimmune attacks.

With this distinction becoming clear, scientists hope to develop new advances for treating autoimmune diseases like type 1 diabetes. Here is how it all works:

In the body, there is an amount of white blood cells known as CD8+ Treg cells. These cells exist to help fight against bacteria in the body, they not only kill an infected virus they can also kill tumor cells. CD8+ Treg cells have the ability to counteract autoimmune attacks on the body, which allow cells to be increased through a chemical process, all the while, reducing antibodies that attack tissue within an individual’s body. Ultimately, CD8+ cells control autoantibody formation, which is the creation of antibodies that end up attacking the body’s own tissues.

This is all possible due to the bodies “B” cells. B cells are a subpopulation of white cells that exist in the body to make antibodies that connect to pathogens, which helps to accomplish their destruction in the body. When B cells are activated in response to follicular T helper cells, autoantibody formation happens, which results in an unwanted autoimmune attack.

Through this discovery, scientists are now able to focus on B cells, so they can stop antibodies from attacking the body’s cells. Through CD8+ Treg cells, it has become possible to control follicular helper cells, which are more efficient in the body, instead of directly controlling B cells. If scientists can control one follicular cell, they could end controlling many B cells, which in turn helps to stop autoimmune attacks on the body.

This new research will open new doors to medical advancements in autoimmunity diseases. With a large amount of the United States alone being diagnosed with diabetes, there have been large amounts of practical “cures” that have come out through medical advancements in hopes to break the cycle of diabetes. Even herbal remedies have given some relief to those suffering from the disease. However, nothing has come close to being an actual cure for diabetes itself. Scientists believe they may have found the breakthrough needed to cure diabetes and help those suffering from cancer as well.

Living Healthy With My Diabetes™

supervaluThe SUPERVALU family of grocery stores (including Acme®, Albertsons®, Cub Foods®, Farm Fresh®, Jewel-Osco®, Shaw’s/Star Market™, Shop ‘n Save®, and Shoppers Food & Pharmacy®) has just launched “living healthy with my diabetes™,” a program that will feature a variety of year-round resources, as well as special limited-time services starting Nov. 7 through Nov. 20 during American Diabetes Month.

Following are some of the services available between Nov. 7 and Nov. 20:

  • Free blood glucose test screenings in selected locations (Saturday, Nov. 13, from 10 a.m. to 2 p.m.)
  • Health screenings for A1C, cholesterol and liver function for just $19.99
  • And in some stores, savings booklets for discounts on diabetes-related products, while supplies last.

Program elements that are available year-round include:

  • “Eating Healthy with Diabetes” store tours guided by specially-trained pharmacists and registered dietitians
  • Online diabetes-friendly menu ideas and recipes
  • In-store pharmacy services including education, self-management services, blood glucose screenings, blood pressure monitoring and face-to-face medication reviews
  • Diabetes products such as equaline® test strips, glucose tablets, blood pressure monitors, lancets, and latex and vinyl gloves

Better Choices, Better Health Pilot Program

Better Choices, Better Health, the new online version of Stanford University’s Chronic Disease Self Management Program (CDSMP). This new program is free for people in seven pilot states, thanks to a grant from The Atlantic Philanthropies.

National Council on Aging - Better Choices, Better Health ProgramBetter Choices, Better Health, the new online version of Stanford University’s Chronic Disease Self Management Program (CDSMP). This new program is free for people in seven pilot states, thanks to a grant from The Atlantic Philanthropies.

Better Choices, Better Health is a six-week, interactive workshop designed for people with a range of chronic health conditions, including diabetes. Participants learn new ways to manage their symptoms, reduce anxiety, and find community resources.

A little more info about Better Choices, Better Health:

Workshops can be accessed from any computer with an internet connection—including dial-up—making them accessible for those without access to transportation or broadband.

Led by trained facilitators, many of whom live with chronic conditions themselves, participants discuss:

  • Dealing with anxiety and stress
  • Managing pain and other symptoms
  • Planning for the future
  • Locating and using community resources
  • Building communication skills
  • Asking for help

The seven pilot states are: California, Hawaii, Iowa, Maine, Massachusetts, New Jersey, and Oregon. We hope to expand this list soon.

The National Council on Aging has licensed the program from Stanford University, but workshops are open to individuals of all ages.

Even more info: http://www.ncoa.org/improving-health/chronic-disease/better-choices-better-health.html

Ben Vereen Takes Diabetes Personal

Ben VereenHe sings, he dances and he can act. His name is Ben Vereen and he’s a diabetic. This star of stage and screen has taken his story to the people, and the people are listening.

Vereen struggled in his own past. He found out he was adopted in 1960 when applying for a passport to travel. His daughter died. He struggled with alcoholism. A car struck him. Had to learn to speak again after the accident, and more recently was diagnosed with Type 2 diabetes.

Today Vereen is in his 60’s, has a couple of movies and television movies that will debut soon and his one man show featuring music of Sammy Davis Jr. is a success. But according to DallasNews.com Vereen has a new message when it comes to diabetes, “Turn it around.”

Vereen also had a tough message for those who chose to consider themselves a victim of diabetes, “We need to stop seeing diabetes as a challenge or something that we suffer from, but rather it’s an opportunity to live a better life by taking better care of ourselves.”

To demonstrate his level of commitment to fighting diabetes Vereen has partnered with Sanofi-aventis to create an organization S.T.A.N.D. for Diabetes (Start Taking Action Now for Diabetes). The movement is self-described this way, “Whether you are an influencer in the world of entertainment, medicine, public health, or marketing, or someone living with or affected by diabetes in some way, we want you to look for opportunities in your daily activities to spread the message and become part of this movement. We challenge you to think differently about diabetes and imagine new ways to raise awareness about the disease and the importance of better blood sugar control NOW.”

Vereen is clear that it is his influence he plans on using to spread the news about diabetes, its causes, its struggles and ways to fight back. This is the call he makes to all of us – use whatever influence we have to reverse the trend of diabetes in our world.

According to a S.T.A.N.D. press release Vereen said, “When I was first diagnosed I did the things my doctor recommended — watching my diet, exercising more and taking my diabetes medication — but I wasn’t comfortable checking my blood sugar in public, but I’ve overcome my discomfort with the help of friends and family because I’ve learned that it’s so essential to control my blood sugar. Now checking my blood sugar is as comfortable as using my cell phone and my blood sugar is under control!”

Pointing to his optimistic nature Vereen refers to his condition as “lifeabetes.”

One of the key ways S.T.A.N.D. encourages others to influence is through social media like MySpace, Facebook and Twitter. These mediums are a preferred way for many to communicate making them an incredibly potent tool in spreading the news both personally and in wall posts or tweets.

The key reason this is suggested is because it’s easy for everyone to do. There is no need to speak publicly (unless you’re gifted to do so and want to). There is no need to lobby congress (unless you are determined to do so). This is effectively a 21st century attempt at a grassroots movement that spreads the news and invites people to action. People like Ben Vereen – people like you.

Recall of the Medtronic Pumps

In August of 2007, the Medtronic Neuromedulation Company sent a letter to each of its customers. The top of the letter displayed this phrase: “Urgent Medical Device Correction, August 2007.” The letter disclosed some unsettling information about the SynchroMed EL infusion pumps.

In August of 2007, the Medtronic Neuromedulation Company sent a letter to each of its customers. The top of the letter displayed this phrase: “Urgent Medical Device Correction, August 2007.” The letter disclosed some unsettling information about the SynchroMed EL infusion pumps.

The letter sent a clear warning to all those who had purchased a SynchroMed EL infusion pump prior to September of 1999. Mounting evidence had produced proof that pumps made before that date could stall at an unexpectedly high rate. The wear and tear on pumps made before September of 1999 could result in a sudden stoppage of delivery. Stalled pumps ceased delivery of insulin.

The letter emphasized the importance of its message. It indicated that the recall of the SynchroMed EL pump was a Class 1 recall. Any recall constitutes an action taken to address a problem with a product. The FDA can call for the recall of a medical device. A Class I recall underlines the harm that could result from continued and widespread use of a medical device with a particular problem.

The actual recall process had been initiated by the Medtronic Neuromedulation Company. As indicated, the Company had sent letters to each of the customers who had purchased a SynchroMed EL infusion pump. The Company had also completed another important step in the recall process.

When a company recalls a medical device, it needs to do more than just contact those who have previously purchased that device. It also needs to forewarn any customers who might now be thinking about buying that device. When a Company initiates the recall of a medical device, it must also put out a press release. In that release it must make clear what the name of the device that has been shown to be a potential threat to users of that device.

The Medtronic Neuromedulation Company had released such a statement to the press. It had also distributed information that could help customers to better identify the problem pump. Finally, the Company had acted to make the necessary changes in the pumps, changes that would eliminate any potential harm to a diabetes patient who was using that same pump.

The FDA led oversight of the actions taken by the Medtronic Neuromedulation Company. The FDA worked with Company officials to get out clear and complete information on the product that was being recalled. In addition, the FDA had asked the Company to issue a public statement, a statement outlining its recall strategy.

Once the Company had initiated its proposed recall strategy, then the FDA had conducted an audit of the Company. The FDA used that audit as a way to judge the effectiveness of the ongoing recall. The FDA also took steps to monitor the efforts being made to correct the device deficiencies, the deficiencies that had led to the recall.

Although the FDA has designed the recall process to limit the number of consumer concerns, the Agency realizes that some customers might still have questions. For that reason, it has announced several channels by which concerned customers, possibly diabetes patients, can direct their questions to those most apt to have the correct answer.

Diabetes patients who use or have used the SynchroMed EL infusion pump can obtain more information by calling 1-800-707-0923. They can also go online to this website: www.fda.gov/MedWatch/report.html. A diabetes patient who can not make a phone call or does not have access to a computer has yet another option. He or she can send a Fax to 1-800-FDA-0178.

Should a diabetes patient care to mail a letter to the executives at the company conducting the recall, then that patient should address that letter to:

Medtronic Neuromedulation Company
800 53rd Ave. N.E.
P.O. Box 1250
Minneapolis, Minnesota 55440-1250

Diabetes Connection to the Bone Cells

It’s not often that you hear of medical science discussing diabetes and bones in the same sentence. Usually the heart and kidneys are the discussed in connection with diabetes, but new research suggests that the human bones may have a bearing on how the human body manages insulin.

bone cells and diabetesIt’s not often that you hear of medical science discussing diabetes and bones in the same sentence. Usually the heart and kidneys are the discussed in connection with diabetes, but new research suggests that the human bones may have a bearing on how the human body manages insulin.

MedPageToday indicates, “In the July 23 issue of Cell, [and] from two separate research teams [there is an indication] that insulin receptors in osteoblasts mediate release of the hormone osteocalcin, which speeds up glucose metabolism elsewhere in the body.”

MedicineNet.com defines osteoblasts as, “A cell that makes bone.” Meanwhile, “The hormone osteocalcin is secreted solely by osteoblasts (bone making cells) and thought to play a role in the body’s metabolic regulation and is pro-osteoblastic, or bone-building,” according to Wikipedia.

According to Gerard Karsenty, MD, PhD, of Columbia University in New York City, “The two studies suggest that drugs working through the osteocalcin pathway, if not the hormone itself, could be effective treatments for type 2 diabetes.

“Insulin signaling in osteoblasts [is] a critical link between bone remodeling and energy metabolism,” cited MedPageToday.com

The exciting part of this research is the fact that this provides a new link of potential in how the body works to correct health issues. As mentioned in the opening paragraph it is not often that anyone has spoken about diabetes and bone health in the same sentence.

The end result could be that individuals with diabetes may want to gain as much information about how the human bones can actually help regular blood sugar (glucose) as possible.

MedPageToday indicated these, “experiments also revealed what they called a “previously unappreciated” function of insulin in bone — that it boosts activity of an osteoblast regulatory molecule called Runx2, the end effect being that insulin helps promote osteoblast differentiation.”

The research on this finding was “funded by the Fond de la Recherche en Sante du Quebec, the National Institutes of Health, and the Juvenile Diabetes Research Foundation.”

The long and short of the research suggests that it is possible the bone making cells interact in a more significant way with diabetes by infusing the hormone osteocalcin into the body. This hormone is helpful in regulating diabetes. The hormone appears to act in concert with the bone-making cells to create an atmosphere that is equipped to help with the in-body care needed to thrive with diabetes.

According to MedPageToday both research groups suggested, “In total, the findings demonstrate the delicate and interactive nature of the processes underlying bone formation and resorption.”

The research may further indicate what possible ways this knowledge can be used to accelerate the body’s ability to accept a more efficient flow of information and successful implementation and absorption of insulin within the body, and used by bone making cells.

The body is a very complex organism that is often discovered to be more complex than we ever realized. DNA is an example of the complexity, but even within that undeniably unique set of body blue prints we continue to learn more and more about not only the various parts of our internal structure, but also how those parts interact in ways we never imagined.

These latest studies remain a prime example of how that plays out in scientific data and potential medical fixes for those occasions when two parts of the body that normally work well together are in the midst of a struggle.